Home > 暂无记录 暂无记录 行业新闻

行业新闻


  • Pertuzumab MA1037

    Pertuzumab, a monoclonal antibody against ERBB2 (HER2), is used in the treatment of HER2 positive breast cancer.

    More
  • Ranibizumab MA1038

    Ranibizumab, a humanized, affinity-matured VEGF antibody fragment that neutralizes all isoforms of VEGF, is approved for use in ophthalmology.

    More
  • Rituximab MA1039

    Rituximab, a monoclonal antibody directed at CD20 positive B-lymphocytes, is the first-line treatment of acquired thrombotic thrombocytopenic purpura.

    More
  • Muromonab—CD3 MA1029

    Muromonab CD3 (OKT3), the murine anti-CD3 monoclonal antibody of the IgG-2a class, used as a powerful immunosuppressive agent in solid organ transplantation and the first-line treatment of acute allograft rejection.

    More
  • Natalizumab MA1030

    Natalizumab is a humanized monoclonal antibody against α4 integrins highly effective in relapsing-remitting multiple sclerosis (MS).

    More
  • Current page4, Total Pages305, Total Record1522 First Prev 23456 Next Last Goto